REVIEWS
IMAJ | volume 27
Journal 6, June 2025
pages: 398-404
Guidelines for the Treatment of Infantile Hemangiomas: A Position Paper from the Israeli Association of Dermatology and Venereology
- Ayelet Ollech ,
- Yizhak Confino ,
- Rivka Friedland ,
- Dan Ben Amitai,
- Vered Molho-Pessach,
- Michal Neumark ,
- Jacob Mashiah ,
- Liat Samuelov ,
- Ayelet Shani-Adir,
- Hiba Zaaroura ,
- Eran Cohen-Barak,
- Amir Horev ,
- Yulia Valdman ,
- Baruch Kaplan ,
- Shoshana Greenberger
1 Pediatric Dermatology Service, Shaare Zedek Medical Center, affiliated with Hadassah–Hebrew University School of Medicine, Jerusalem, Israel
2 Pediatric Dermatology Service, Wolfson Medical Center, Holon, Israel
3 Pediatric Dermatology Unit, Schneider Children's Medical Center, Petah Tikva, Israel
4 Department of Dermatology, Pediatric Dermatology Service, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel
5 Department of Dermatology, Pediatric Dermatology Unit, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
6 Department of Pediatrics, Carmel Medical Center, Haifa, Israel
7 Department of Dermatology, Rambam Health Care Campus, Haifa, Israel
8 Department of Dermatology, Emek Medical Center, Afula, Israel
9 Pediatric Dermatology Service, Soroka University Medical Center, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel
10 Department of Dermatology, Soroka University Medical Center, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel
11 Adelson School of Medicine, Ariel University, Ariel, Israel
12 Assuta Medical Center, Tel Aviv, Israel
13 Department of Dermatology, Pediatric Dermatology Unit, Sheba Medical Center, Tel Hashomer, Israel
14 Gray Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel
15 Rappaport Faculty of Medicine, Technion–Israel Institute of Technology, Haifa, Israel
16 Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel
Summary
Infantile hemangioma (IH) is the most common benign vascular tumor in infancy. Recent advances, particularly in beta-blocker therapy, have significantly improved the management of IHs. Early identification and treatment of IH may help reduce morbidity and associated complications. In this review, experts in pediatric dermatology in Israel who have experience in treating IH formulated national guidelines for the diagnosis and treatment of IHs, providing evidence-based recommendations for selecting appropriate therapeutic approaches. These Israeli national guidelines provide a structured approach to the diagnosis and treatment of IH, emphasizing early referral, appropriate treatment selection, and careful monitoring. The guidelines serve as a critical resource for pediatricians and dermatologists, ensuring optimal patient outcomes while minimizing complications.